Retracted: Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567502/
https://www.ncbi.nlm.nih.gov/pubmed/37829540
http://dx.doi.org/10.1155/2023/9837485
_version_ 1785119143040647168
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-10567502
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105675022023-10-12 Retracted: Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-10-04 /pmc/articles/PMC10567502/ /pubmed/37829540 http://dx.doi.org/10.1155/2023/9837485 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
title Retracted: Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
title_full Retracted: Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
title_fullStr Retracted: Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
title_full_unstemmed Retracted: Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
title_short Retracted: Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia
title_sort retracted: research progress of b-cell lymphoma/leukemia-2 inhibitor combined with azacytidine in the targeted therapy of acute myeloid leukemia
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567502/
https://www.ncbi.nlm.nih.gov/pubmed/37829540
http://dx.doi.org/10.1155/2023/9837485
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedresearchprogressofbcelllymphomaleukemia2inhibitorcombinedwithazacytidineinthetargetedtherapyofacutemyeloidleukemia

Ejemplares similares